| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 12 | 0 | 0 | 12 |
| GLI family zinc finger 3 | 10 | 0 | 0 | 10 |
| AR protein | 18 | 0 | 0 | 18 |
| aldehyde dehydrogenase 1 family, member A1 | 10 | 0 | 0 | 10 |
| retinoic acid nuclear receptor alpha variant 1 | 12 | 0 | 0 | 12 |
| retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
| estrogen nuclear receptor alpha | 19 | 0 | 0 | 19 |
| peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 8 | 0 | 0 | 8 |
| activating transcription factor 6 | 5 | 0 | 0 | 5 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 10 | 0 | 0 | 10 |
| Histone H2A.x | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
| heat shock protein beta-1 | 5 | 0 | 0 | 5 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
| lamin isoform A-delta10 | 10 | 0 | 0 | 10 |
| Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
| Glutamate receptor 2 | 6 | 0 | 0 | 6 |
| glucocorticoid receptor [Homo sapiens] | 10 | 0 | 0 | 10 |
| euchromatic histone-lysine N-methyltransferase 2 | 13 | 0 | 0 | 13 |
| peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 8 | 0 | 0 | 8 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 8 | 0 | 0 | 8 |
| phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| GLS protein | 7 | 0 | 0 | 7 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 6 | 0 | 0 | 6 |
| chromobox protein homolog 1 | 7 | 0 | 0 | 7 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
| muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Cytochrome P450 3A4 | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
| ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
| Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
| arylsulfatase A | 5 | 0 | 0 | 5 |
| Bloom syndrome protein isoform 1 | 9 | 0 | 0 | 9 |
| Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
| Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
| Glutamate transporter homolog | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 1 | 0 | 4 | 0 | 5 |
| Carbonic anhydrase 2 | 0 | 4 | 0 | 5 |
| N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Excitatory amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Excitatory amino acid transporter 2 | 0 | 1 | 0 | 1 |
| Excitatory amino acid transporter 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
| pregnane X nuclear receptor | 10 | 0 | 0 | 10 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| ATP-binding cassette sub-family C member 3 | 0 | 5 | 0 | 5 |
| Multidrug resistance-associated protein 4 | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
| Bile salt export pump | 0 | 9 | 0 | 9 |
| Muscarinic acetylcholine receptor M2 | 0 | 9 | 4 | 17 |
| Muscarinic acetylcholine receptor M4 | 0 | 8 | 3 | 14 |
| Muscarinic acetylcholine receptor M1 | 0 | 7 | 2 | 14 |
| Muscarinic acetylcholine receptor M3 | 0 | 7 | 2 | 13 |
| Muscarinic acetylcholine receptor M4 | 0 | 7 | 1 | 12 |
| Muscarinic acetylcholine receptor M5 | 0 | 7 | 1 | 12 |
| Muscarinic acetylcholine receptor M5 | 0 | 9 | 3 | 15 |
| Muscarinic acetylcholine receptor M2 | 0 | 8 | 1 | 14 |
| Muscarinic acetylcholine receptor M1 | 0 | 9 | 5 | 18 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 2 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 8 | 3 | 14 |
| Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 6 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 3 | 0 | 0 | 4 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 3 | 1 | 4 |
| Canalicular multispecific organic anion transporter 1 | 0 | 5 | 0 | 5 |
| Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
| acetylcholinesterase | 8 | 0 | 0 | 8 |
| GALC protein | 1 | 0 | 0 | 1 |
| TDP1 protein | 7 | 0 | 0 | 7 |
| peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
| IDH1 | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
| geminin | 7 | 0 | 0 | 7 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 1 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 3 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
| Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 6 | 0 | 7 |
| Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
| Chain A, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain B, HADH2 protein | 5 | 0 | 0 | 5 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| Fumarate hydratase | 2 | 0 | 0 | 2 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
| EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
| estrogen-related nuclear receptor alpha | 11 | 0 | 0 | 11 |
| farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
| cytochrome P450 2D6 | 9 | 0 | 0 | 9 |
| polyprotein | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 isoform 1 | 5 | 0 | 0 | 5 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 6 | 0 | 0 | 6 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 9 | 0 | 0 | 9 |
| chaperonin GroEL | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
| Interferon beta | 6 | 0 | 0 | 6 |
| Cellular tumor antigen p53 | 10 | 0 | 0 | 10 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 5 | 1 | 6 |
| Glycogen phosphorylase, brain form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 5 | 0 | 5 |
| Alpha-2C adrenergic receptor | 0 | 3 | 1 | 4 |
| D | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 4 | 0 | 4 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 4 | 0 | 4 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 1B | 0 | 4 | 0 | 4 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 2 | 1 | 3 |
| D(3) dopamine receptor | 0 | 4 | 0 | 4 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
| Spike glycoprotein | 5 | 0 | 0 | 5 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Histone-lysine N-methyltransferase SETD7 | 0 | 2 | 0 | 2 |
| Ataxin-2 | 2 | 0 | 0 | 2 |
| Transporter | 0 | 1 | 0 | 1 |
| USP1 protein, partial | 7 | 0 | 0 | 7 |
| Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
| Genome polyprotein | 0 | 1 | 1 | 2 |
| Luciferase | 6 | 0 | 0 | 6 |
| chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
| SMAD family member 2 | 5 | 0 | 0 | 5 |
| SMAD family member 3 | 5 | 0 | 0 | 5 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| G | 3 | 0 | 0 | 3 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
| aryl hydrocarbon receptor | 7 | 0 | 0 | 7 |
| vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
| DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
| Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
| Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
| large T antigen | 0 | 1 | 0 | 1 |
| Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
| Taste receptor type 2 member 16 | 0 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
| progesterone receptor | 6 | 0 | 0 | 6 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Asialoglycoprotein receptor 1 | 0 | 1 | 1 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit pi | 5 | 0 | 0 | 5 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
| Lysine-specific histone demethylase 1A | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 2 | 0 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| Integrin alpha-IIb | 2 | 0 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 0 | 0 | 5 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 0 | 0 | 5 |
| Mu-type opioid receptor | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 0 | 0 | 5 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
| GABA theta subunit | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit epsilon | 5 | 0 | 0 | 5 |
| Carboxylic ester hydrolase | 0 | 3 | 0 | 3 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | 0 | 1 | 0 | 1 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Nischarin | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Heparanase | 0 | 0 | 1 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| Free fatty acid receptor 1 | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Trypsin | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, heart | 0 | 2 | 0 | 2 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 2 | 0 | 2 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, adipocyte | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 7 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein 5 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
| Free fatty acid receptor 4 | 0 | 0 | 1 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 4 | 0 | 4 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| dopamine D1 receptor | 2 | 0 | 0 | 2 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
| glucokinase regulatory protein | 2 | 0 | 0 | 2 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 2 |
| DNA gyrase subunit B | 0 | 1 | 0 | 2 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 2 |
| DNA gyrase subunit A | 0 | 1 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
| Acetylcholinesterase | 0 | 2 | 0 | 3 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 2 | 0 | 3 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| luciferase | 0 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Glucocorticoid receptor | 0 | 2 | 1 | 8 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Albumin | 0 | 1 | 0 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Stromelysin-1 | 0 | 0 | 1 | 1 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 2 | 0 | 4 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Ubiquitin-like modifier activating enzyme 2 | 0 | 1 | 0 | 1 |
| SUMO1 activating enzyme subunit 1 | 0 | 1 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| hexokinase | 0 | 1 | 0 | 1 |
| SUMO-conjugating enzyme UBC9 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
| Vif | 0 | 1 | 0 | 1 |
| Tat | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein phosphatase F | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 6 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 11 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |